Saturday 17 October 2026
Export VEEV’s income statement to Excel — free account
Veeva Systems Inc.
VEEV Healthcare Health Information Services
Veeva Systems Inc.’s revenue for fiscal 2026 (year ended January 2026) was $3.2 billion, up 16.3% from fiscal 2025. In the quarter to July 2026, revenue grew 17.6%, EPS grew 36.6% and free cash flow was flat, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years, operating cash flow growth for ten.
310.30
2.73
−0.87%
Follow VEEV
| Older periods | Oct '25 | Jan '26 | Apr '26 | Jul '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
55.26 | 36.57 | 27.08 | 32.81 |
P/S ratio |
15.51 | 10.42 | 7.68 | 9.57 | |
P/FCF ratio |
35.36 | 24.01 | 15.53 | 20.19 | |
P/Operating CF |
247.79 | 311.49 | 22.60 | 138.59 | |
P/B ratio |
6.79 | 4.61 | 3.49 | 4.45 | |
Price to Tangible BV |
7.27 | 4.93 | 3.77 | 4.81 | |
EV/Sales |
13.35 | 8.36 | 5.47 | 7.47 | |
EV/EBITDA |
45.50 | 27.80 | 18.10 | 23.81 | |
EV/Operating CF |
29.85 | 18.88 | 10.91 | 15.52 | |
EV/FCF |
30.44 | 19.28 | 11.07 | 15.77 | |
Quick Ratio |
7.42 | 4.81 | 4.67 | 5.36 | |
Current Ratio |
7.53 | 4.89 | 4.74 | 5.46 | |
Net Debt/EBITDA |
(26.29) | (25.69) | (25.41) | (25.00) | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.42 | 0.39 | 0.39 | 0.41 | |
Operating CF/Net income |
0.82 | 0.44 | 4.32 | 0.87 | |
Capex/Depreciation |
(0.85) | (0.74) | (0.12) | (0.54) | |
Research and Development Expense of Revenue |
23.65% | 23.78% | 23.59% | 24.02% | |
Selling, General and Administrative Expense of Revenue |
22.07% | 21.27% | 20.45% | 21.34% | |
Intangible Assets out of Total Assets |
0.06 | 0.05 | 0.06 | 0.06 | |
Share Based Compensation of Revenue |
14.83% | 14.15% | 13.51% | 14.74% | |
Graham Net Nets |
0.13 | 0.19 | 0.24 | 0.19 | |
Graham Number |
71.34 | 74.26 | 76.13 | 79.98 | |
Earnings Yield |
1.81% | 2.73% | 3.69% | 3.05% | |
Free Cash Flow Yield |
2.83% | 4.16% | 6.44% | 4.95% | |
Revenue per Share |
4.95 | 5.11 | 5.41 | 5.72 | |
Operating CF per Share |
1.18 | 0.65 | 6.90 | 1.47 | |
Capex per Share |
(0.06) | (0.04) | (0.01) | (0.05) | |
Free Cash Flow per Share |
1.11 | 0.61 | 6.89 | 1.42 | |
Cash per Share |
40.46 | 40.09 | 44.77 | 44.61 | |
Shareholders Equity per Share |
42.92 | 44.08 | 44.72 | 45.78 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
42.92 | 44.08 | 44.72 | 45.78 | |
Free Cash Flow |
182.90 | 99.82 | 1,125.37 | 230.69 | |
Working Capital |
6,166.98 | 6,360.57 | 6,361.49 | 6,490.28 | |
Capital Expenditures |
(9.89) | (7.03) | (1.75) | (8.02) | |
Net Current Asset Value |
6,055.33 | 6,233.04 | 6,238.06 | 6,317.45 | |
EV/EBIT |
47.89 | 29.16 | 19.01 | 24.97 | |
Capex to Sales |
0.01 | 0.01 | 0.00 | 0.01 | |
Price to Operating Income |
55.62 | 36.32 | 26.66 | 31.97 | |
| Other line items | |||||
Average Receivables |
336.53 | 1,183.73 | 584.53 | 519.03 | |
Average Payables |
32.26 | 34.05 | 39.04 | 34.78 | |
Average Assets |
7,275.00 | 8,159.55 | 8,447.32 | 8,529.83 | |
Average Common Equity |
6,271.02 | 6,523.56 | 6,757.73 | 7,034.99 |
Columns are period end dates